Insider trades

John Greene, Director of Crispr Therapeutics CRSP, has filed 1 purchase and 1 sale on the open market. The latest trade was on 06/05.

John Greene

Director
First filing
23/02/03
Trades
22 trades
Buys / sales
1 / 1
12-month net buying
No record
Last trade
06/05

Trading activity

Transactions

Trade type
Open-market buy25/02/2625/02/287,000 sh$44.85$313,950No record
Open-market sale24/01/2624/01/3035,191 sh$106.51$3,748,193.41−65.4%